Dsuvia

(sufentanil)
sufentanil 0.03 MG Sublingual Tablet [Dsuvia]

Dosage & administration

• Recommended dosage is 30 mcg sublingually as needed with a minimum of one hour between doses. ( 2.2)
• Do not exceed 12 tablets in 24 hours. ( 2.2)
• See the Full Prescribing Information for administration information. ( 2.3)
• Do not discontinue DSUVIA abruptly in a physically-dependent patient. ( 9.3)


drug label

Dsuvia prescribing information

Have more Dsuvia questions?

Submit MSL Request
Learn More

Need to report a Dsuvia issue?

ONLINE FORM
Report adverse event
Learn More

prior authorization

Dsuvia Prior authorization resources

NOT PROVIDED BY BRAND
Complete Letter of Medical Necessity

NOT PROVIDED BY BRAND
Coverage Authorization Request

NOT PROVIDED BY BRAND
Coverage Authorization Appeals
Learn More

Benefits investigation

NOT PROVIDED BY BRAND
Benefits investigation resources
Learn More

Reimbursement help (FRM)

Receive Assistance from an FRM Regarding Reimbursement Information
Learn More

financial assistance

Dsuvia Financial assistance options

Co-pay savings program

commercial only

NOT PROVIDED BY BRAND
Enroll in Patient Savings Program
Learn More

Bridge program

commercial only
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+
Learn More

patient education

Dsuvia Patient education

Getting started on Dsuvia

Instructions For Use - Acute Pain Management
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Patient toolkit

NOT PROVIDED BY BRAND
Not Provided By Brand
Learn More

people also ask

Dsuvia FAQs

FAQ Data Source

Can't find what you're looking for?

Our trained staff can help you:
Please note:
  • Access to a Field Reimbursement Manager (FRM) or Medical Science Liaison (MSL) varies by brand and may require talking with your rep first.
  • Samples are provided at the discretion of the brand.
  • We are unable to collect Protected Health Information (PHI), fill out forms, or submit them on your behalf.